SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that COVID-19 RT-PCR testing volume has increased in 2022 ...
Researchers have built an RT-PCR platform that gives results in 23 minutes that match the longer laboratory-based tests -- faster than other PCR tests on the market. It can be adapted to test for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results